{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:31Z","timestamp":1786136011066,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Diabetes mellitus is a chronic disease that significantly affects global mortality rates, particularly among critically ill individuals. While previous studies have highlighted the role of glucose regulation and platelet activity in mortality risk, the combined impact of blood glucose and platelet levels remains underexplored. This study aims to investigate the relationship between the blood glucose-to-platelet ratio (BPR) and all-cause mortality in critically ill diabetic patients. A retrospective analysis was conducted using the MIMIC-IV database, which included 21,145 critically ill diabetic patients admitted to the intensive care unit. Patients were categorized into quartiles based on their BPR. Mortality rates at 28 and 360 days post-admission were assessed. Cox proportional hazards models were used to evaluate the association between BPR and hospital mortality, adjusting for potential confounders such as age, sex, comorbidities, and illness severity scores. Restricted cubic spline analysis was applied to assess the nonlinear relationship between BPR and hospital mortality. The median age of patients was 69 years (interquartile range, 60\u201378), with 58.41% male. The crude 28-day and 360-day hospital mortality rates were 10.83% and 15.57%, respectively. Higher BPR quartiles were associated with increased mortality rates at both 28 days and 360 days (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). The hazard ratio for 28-day hospital mortality between the highest (Q4) and lowest (Q1) quartiles was 1.69 in the unadjusted model and 1.36 after adjusting for confounders. Analysis using restricted cubic splines suggested a nonlinear relationship between BPR and hospital mortality, with an increase in risk observed as BPR levels increased. Subgroup analyses revealed consistent associations across different patient demographics and comorbid conditions, including age, sex, and sepsis. BPR appears to be a potential marker for predicting all-cause mortality in critically ill diabetic patients, with a moderate association between BPR and mortality risk. While the blood glucose-to-platelet ratio could serve as a useful tool for identifying high-risk patients, its clinical applicability in intensive care unit settings requires further investigation. Future studies should explore its role in dynamic monitoring and therapeutic interventions, as well as address the limitations of our current findings, such as the observational nature of the data and potential confounding factors.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050128","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:01:31Z","timestamp":1786125691000},"page":"e50128","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of the blood glucose-to-platelet ratio with all-cause mortality in diabetic patients: An analysis of the MIMIC-IV database"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6980-1134","authenticated-orcid":false,"given":"Yinan","family":"Zhao","sequence":"first","affiliation":[{"name":"Clinical Medical College of Qinghai University, Qinghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatology II, Fourth People\u2019s Hospital of Qinghai Province, Qinghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9047-9029","authenticated-orcid":false,"given":"Guoying","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hepatology II, Fourth People\u2019s Hospital of Qinghai Province, Qinghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260807","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021.","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"R2-20260807","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.2147\/IJN.S508875","article-title":"Nano-based drug delivery systems for managing diabetes: recent advances and future prospects.","volume":"20","author":"Liu","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"R3-20260807","doi-asserted-by":"crossref","first-page":"6612063","DOI":"10.1155\/2021\/6612063","article-title":"Nanotechnology in the treatment of diabetic complications: a comprehensive narrative review.","volume":"2021","author":"He","year":"2021","journal-title":"J Diabetes Res"},{"key":"R4-20260807","doi-asserted-by":"crossref","first-page":"22623","DOI":"10.1021\/acsomega.3c01034","article-title":"In vitro, in silico, and in vivo studies of cardamine hirsuta linn as a potential antidiabetic agent in a rat model.","volume":"8","author":"Malik","year":"2023","journal-title":"ACS Omega"},{"key":"R5-20260807","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0001-2092(06)61065-X","article-title":"Diabetes mellitus and its chronic complications.","volume":"76","author":"Bailes","year":"2002","journal-title":"AORN J"},{"key":"R6-20260807","doi-asserted-by":"crossref","first-page":"359","DOI":"10.15585\/mmwr.mm6712a2","article-title":"Prevalence of diagnosed diabetes in adults by diabetes type - United States, 2016.","volume":"67","author":"Bullard","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20260807","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/10815589221145040","article-title":"Pathophysiology and diagnosis of diabetic retinopathy: a narrative review.","volume":"71","author":"Estaji","year":"2023","journal-title":"J Investig Med"},{"key":"R8-20260807","doi-asserted-by":"crossref","first-page":"1144918","DOI":"10.3389\/fphar.2023.1144918","article-title":"Treatment of obesity-related diabetes: significance of thermogenic adipose tissue and targetable receptors.","volume":"14","author":"Pan","year":"2023","journal-title":"Front Pharmacol"},{"key":"R9-20260807","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4093\/dmj.2020.0175","article-title":"Trends in cardiovascular complications and mortality among patients with diabetes in South Korea.","volume":"45","author":"Park","year":"2021","journal-title":"Diabetes Metab J"},{"key":"R10-20260807","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/ars.2022.0028","article-title":"Hydrogen sulfide in diabetic complications revisited: the state of the art, challenges, and future directions.","volume":"38","author":"Sun","year":"2023","journal-title":"Antioxid Redox Signal"},{"key":"R11-20260807","doi-asserted-by":"crossref","first-page":"681","DOI":"10.14744\/nci.2023.01205","article-title":"Evaluation of the relation between HBA1C and MPV, PDW levels of patients with Type 2 diabetes admitted in internal medicine polyclinics.","volume":"10","author":"Aktas","year":"2023","journal-title":"North Clin Istanb"},{"key":"R12-20260807","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3390\/jcm12051913","article-title":"Platelet reactivity and cardiovascular mortality risk in the LURIC study.","volume":"12","author":"Berger","year":"2023","journal-title":"J Clin Med"},{"key":"R13-20260807","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/jpm13060997","article-title":"Predictors of carbohydrate metabolism disorders and lethal outcome in patients after myocardial infarction: a place of glucose level.","volume":"13","author":"Kononova","year":"2023","journal-title":"J Pers Med"},{"key":"R14-20260807","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.4239\/wjd.v15.i9.1889","article-title":"Platelet indices as predictors of poor glucoregulation in type 2 diabetes mellitus adults at Bishoftu General Hospital, Ethiopia.","volume":"15","author":"Regassa","year":"2024","journal-title":"World J Diabetes"},{"key":"R15-20260807","doi-asserted-by":"crossref","first-page":"670155","DOI":"10.3389\/fphar.2021.670155","article-title":"Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease.","volume":"12","author":"Nusca","year":"2021","journal-title":"Front Pharmacol"},{"key":"R16-20260807","doi-asserted-by":"crossref","first-page":"6938629","DOI":"10.1155\/2020\/6938629","article-title":"Increased intraplatelet ADMA level may promote platelet activation in diabetes mellitus.","volume":"2020","author":"Gawry\u015b","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R17-20260807","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4103\/njcp.njcp_477_19","article-title":"The effects of blood glucose regulation and treatment regime on mean platelet volume in type 2 diabetic patients.","volume":"24","author":"Alay","year":"2021","journal-title":"Niger J Clin Pract"},{"key":"R18-20260807","doi-asserted-by":"crossref","first-page":"e3290","DOI":"10.1002\/dmrr.3290","article-title":"Impact of diabetes mellitus on immature platelet fraction and its association with coronary artery disease.","volume":"36","author":"Verdoia","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"R19-20260807","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset.","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"R20-20260807","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study.","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"key":"R21-20260807","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system.","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"R22-20260807","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \u201csepsis-related problems\u201d of the European Society of Intensive Care Medicine.","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"key":"R23-20260807","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the european society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R24-20260807","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R25-20260807","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.kint.2020.07.035","article-title":"A practical guide to multiple imputation of missing data in nephrology.","volume":"99","author":"Blazek","year":"2021","journal-title":"Kidney Int"},{"key":"R26-20260807","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fneur.2020.00456","article-title":"Triglyceride glucose index and prognosis of patients with ischemic stroke.","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Neurol"},{"key":"R27-20260807","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/jpm14010089","article-title":"Association between relative thrombocytosis and microalbuminuria in adults with mild fasting hyperglycemia.","volume":"14","author":"Choi","year":"2024","journal-title":"J Pers Med"},{"key":"R28-20260807","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/jdi.13606","article-title":"Effect of glycemic gap upon mortality in critically ill patients with diabetes.","volume":"12","author":"Lou","year":"2021","journal-title":"J Diabetes Investig"},{"key":"R29-20260807","doi-asserted-by":"crossref","first-page":"817","DOI":"10.5005\/jp-journals-10071-23574","article-title":"Platelet indices as predictive markers of prognosis in critically Ill patients: a prospective study.","volume":"24","author":"Samuel","year":"2020","journal-title":"Indian J Crit Care Med"},{"key":"R30-20260807","doi-asserted-by":"crossref","first-page":"112009","DOI":"10.1016\/j.diabres.2025.112009","article-title":"Association of glycemic variability with short and long-term mortality among critically ill patients with heart failure: analysis of the MIMIC-IV database.","volume":"221","author":"Shuai","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"R31-20260807","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjsurg.2018.10.024","article-title":"Association between acute phase perioperative glucose parameters and postoperative outcomes in diabetic and non-diabetic patients undergoing non-cardiac surgery.","volume":"218","author":"Nair","year":"2019","journal-title":"Am J Surg"},{"key":"R32-20260807","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jtcvs.2024.01.013","article-title":"Long-term results of atrial fibrillation surgery concomitant with mitral valve surgery: a propensity score-matched multicenter study.","volume":"168","author":"Kim","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R33-20260807","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1097\/CCM.0000000000001958","article-title":"Atrial fibrillation following out-of-hospital cardiac arrest and targeted temperature management-Are we giving it the attention it deserves?","volume":"44","author":"Thomsen","year":"2016","journal-title":"Crit Care Med"},{"key":"R34-20260807","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/IMI.0000000000000570","article-title":"Management of atrial fibrillation in patients undergoing coronary artery bypass grafting: review of the literature.","volume":"13","author":"Khiabani","year":"2018","journal-title":"Innovations (Phila)"},{"key":"R35-20260807","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.hrthm.2018.08.023","article-title":"Prognostic efficacy of platelet count in patients with nonvalvular atrial fibrillation.","volume":"16","author":"Park","year":"2019","journal-title":"Heart Rhythm"},{"key":"R36-20260807","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1590\/1806-9282.20220295","article-title":"Systemic immune-inflammation index as a novel predictor of atrial fibrillation after off-pump coronary artery bypass grafting.","volume":"68","author":"Topal","year":"2022","journal-title":"Rev Assoc Med Bras (1992)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:02:24Z","timestamp":1786132944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":36,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050128","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"2025-12-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}